LabCorp Is Scheduled To Present at the Merrill Lynch Health Services Investor Conference

BURLINGTON, N.C., Nov. 27 /PRNewswire-FirstCall/ -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) today announced that David P. King, Executive Vice President and Chief Operating Officer, Bradford T. Smith, Executive Vice President, Corporate Affairs, and William (Brad)

LabCorp to Dedicate New Facility at Burlington Corporate Headquarters

BURLINGTON, NC, November. 8, 2006 -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) will hold a dedication ceremony on November 16, 2006, at 10:00 a.m. for a new facility the company is constructing in Burlington, North Carolina.

LabCorp(R) Announces Accelerated Share Repurchase Agreement

Company Purchases $250 Million of Common Stock Under Accelerated Share Repurchase Agreement BURLINGTON, N.C., Nov. 6 /PRNewswire-FirstCall/ -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) today announced that it has entered into an accelerated share repurchase agreement

LabCorp is Scheduled to Present at the Cowen and Company 7th Annual Global Health Care Conference

BURLINGTON, N.C., Nov. 3 /PRNewswire-FirstCall/ -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) today announced that David P. King, Executive Vice President and Chief Operating Officer, Bradford T. Smith, Executive Vice President, Corporate Affairs, and William (Brad)

Laboratory Corporation of America(R) Holdings Announces 2006 Third Quarter Results and Stock Repurchase Program

EBITDA Margin Growth Drives Operating Cash Flow of $155.0 million and EPS Increase of 22.9 Percent, Board of Directors Authorizes Additional $500 Million Share Repurchase Program BURLINGTON, N.C., Oct. 24 /PRNewswire-FirstCall/ -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE:

Laboratory Corporation of America(R) Holdings Announces Final Results of Exchange Offer for Outstanding Liquid Yield Option(TM) Notes Due 2021

BURLINGTON, N.C., Oct. 23 /PRNewswire-FirstCall/ -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) announced today the final results of its offer to exchange a new series of Zero Coupon Convertible Subordinated Notes due September 11, 2021 (the New Notes) and an exchange fee

LabCorp Selected Exclusive National Laboratory for UnitedHealthcare; Will also Develop and Manage Lab Networks Selectively Across the United States

BURLINGTON, N.C., Oct 03, 2006 /PRNewswire-FirstCall via COMTEX News Network/ -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) announced today that it has entered into a new, ten-year agreement (Agreement) with United HealthCare Insurance Company (UnitedHealthcare), an

LabCorp's Liquid Yield Option(TM) Notes Due 2021 Convertible Into Common Stock

BURLINGTON, N.C., Oct. 2 /PRNewswire-FirstCall/ -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) announced today that its $744 million in zero coupon subordinated Liquid Yield Option(TM) Notes (LYONs) due 2021 may be converted into Common Stock of LabCorp at the conversion

LabCorp Is Scheduled To Present at the UBS Global Life Sciences Conference

BURLINGTON, N.C., Sept. 25 /PRNewswire-FirstCall/ -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) today announced that Thomas P. Mac Mahon, Chairman and Chief Executive Officer, David P. King, Executive Vice President and Chief Operating Officer, and Bradford T.

Laboratory Corporation of America(R) Holdings Commences Exchange Offer For its Outstanding Liquid Yield Option(TM) Notes Due 2021

BURLINGTON, N.C., Sept. 22 /PRNewswire-FirstCall/ -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) announced today that it has commenced an exchange offer related to its currently outstanding Liquid Yield Option(TM) Notes (LYONs) due 2021.